Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer.
about
Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF.Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity.Using peripheral blood progenitor cells (PBPC) for transplantation in pediatric patients: a state-of-the-art review.High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II-IIIA breast canDexamethasone, paclitaxel, etoposide, cyclophosphamide (d-TEC) and G-CSF for stem cell mobilisation in multiple myeloma.A phase II trial of docetaxel for peripheral blood stem cell mobilization for patients with breast cancer and ovarian cancer.Intensive chemotherapy for progressive chronic lymphocytic leukemia administered early after a nonmyeloablative allograft.A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters.Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma.Current strategies for the management of autologous peripheral blood stem cell mobilization failures in patients with multiple myeloma.High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation.
P2860
Q33331475-95AA41EF-1825-444B-9506-E7B17BB83819Q33502564-D55C2441-22DD-48AE-9E59-384F287DCD5DQ34165168-D4572C3A-4104-4B20-B7DA-8CC4DB7FF12DQ40554971-16A2A2E3-DF29-467F-BE77-FD9A2AC434CFQ40597777-A17A8B70-0528-4ADF-A979-CE0EBC30FFDCQ40602756-F42A02B9-A5F8-476B-A1AC-5126E54791A0Q43848085-B7911AF4-C83D-455E-ABB6-73117D652027Q44038909-56C46DCA-2DE7-425A-A9A3-0C4CEF47186CQ44589409-DB727B72-8319-4692-9C3C-A5FDAA1BE9CFQ47914097-28BF1B7E-DC10-4CAF-B1AC-7739FDB7E119Q47931203-CD21F367-EBF8-4255-BCB1-CCAD8CB90F56
P2860
Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Peripheral-blood stem-cell col ...... ith breast and ovarian cancer.
@ast
Peripheral-blood stem-cell col ...... ith breast and ovarian cancer.
@en
type
label
Peripheral-blood stem-cell col ...... ith breast and ovarian cancer.
@ast
Peripheral-blood stem-cell col ...... ith breast and ovarian cancer.
@en
prefLabel
Peripheral-blood stem-cell col ...... ith breast and ovarian cancer.
@ast
Peripheral-blood stem-cell col ...... ith breast and ovarian cancer.
@en
P2093
P50
P1476
Peripheral-blood stem-cell col ...... ith breast and ovarian cancer.
@en
P2093
K Schiffman
W I Bensinger
P304
P356
10.1200/JCO.1995.13.7.1714
P407
P577
1995-07-01T00:00:00Z